Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
about
Role of biomarkers in the prediction and diagnosis of hepatocellular carcinomaLatent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinomaCombined detection of liver stiffness and C-reactive protein in patients with hepatitis B virus-related liver cirrhosis, with and without hepatocellular carcinoma.
P2860
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@ast
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@en
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@nl
type
label
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@ast
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@en
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@nl
prefLabel
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@ast
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@en
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@nl
P2093
P2860
P356
P1433
P1476
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
@en
P2093
Asem I Fitian
David R Nelson
Mark A Atkinson
Miguel Ararat
Roniel Cabrera
Todd Brusko
P2860
P304
P356
10.3892/OL.2012.826
P577
2012-07-26T00:00:00Z